Sompo Asset Management Co. Ltd. increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,480 shares of the healthcare conglomerate’s stock after purchasing an additional 150 shares during the quarter. Sompo Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $1,255,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $28,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $32,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have recently commented on UNH. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Erste Group Bank raised UnitedHealth Group to a “strong-buy” rating in a report on Wednesday, April 16th. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating on the stock in a research report on Tuesday. Finally, Raymond James reiterated a “strong-buy” rating and issued a $540.00 price objective (down from $635.00) on shares of UnitedHealth Group in a research note on Monday. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $608.00.
UnitedHealth Group Price Performance
NYSE:UNH opened at $427.10 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $508.83 and a 200 day simple moving average of $537.99. UnitedHealth Group Incorporated has a 1-year low of $417.12 and a 1-year high of $630.73. The stock has a market capitalization of $390.67 billion, a PE ratio of 27.55, a P/E/G ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the business earned $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.97%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 35.18%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- The Risks of Owning Bonds
- Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY
- 3 Healthcare Dividend Stocks to Buy
- Fundamentally Sound Verizon Pulls Back Into Buying Opportunity
- Canadian Penny Stocks: Can They Make You Rich?
- Could Palantir’s Latest Partnership Set a Base for a Move Higher?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.